Artificial intelligence is on the brink of its next great leap. After years dominated by generative AI, 2025 is shaping up to ...

Increased corporate spending and travel technology innovations drove optimism, despite some controversies associated with the direction and pace of change. Underneath that expectant surface, however, ...

Opinion: Nelson Mullins' Karen Rigberg and Bart Daniel say businesses should focus on reviewing, monitoring, and documenting ...

Addressing these challenges, we propose a new group-based ultralightweight authentication protocol (GBULAP) for TMIS. The protocol introduces a novel indexing mechanism for the medical server, ...

Bortezomib is a protease inhibitor and is the first compound in this drug class to be used in clinical practice, with trials demonstrating efficacy in patients with relapsed/refractory multiple ...

Exploring Monad compares across multiple architectural and performance dimensions, including many technical aspects.